We are live on ! Find out more
OBGC

O'Brien Greene & Co Portfolio holdings

AUM $353M
1-Year Est. Return 30.94%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+30.94%
3 Year Est. Return
+79.57%
5 Year Est. Return
+109.64%
10 Year Est. Return
AUM
$353M
AUM Growth
+$16.5M
Cap. Flow
-$3.85M
Cap. Flow %
-1.09%
Top 10 Hldgs %
39.64%
Holding
147
New
11
Increased
37
Reduced
34
Closed
14

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$7.16M
2
BR icon
Broadridge
BR
+$6.99M
3
FDX icon
FedEx
FDX
+$4.27M
4
TLN
Talen Energy Corp
TLN
+$2.3M
5
ADP icon
Automatic Data Processing
ADP
+$1.24M

Sector Composition

Rank Sector Weight
1 Financials 16.07%
2 Energy 14.07%
3 Technology 13.61%
4 Materials 10.77%
5 Industrials 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IUSG icon
126
iShares Core S&P US Growth ETF
IUSG
$31.8B
-1,265
Closed -$212K
MEDP icon
127
Medpace
MEDP
$15.3B
-12,743
Closed -$7.16M
NVRI icon
128
Enviri
NVRI
$638M
-19,000
Closed -$340K
PYPL icon
129
PayPal
PYPL
$50.3B
-4,172
Closed -$244K
SENEA icon
130
Seneca Foods Class A
SENEA
$1.11B
-2,000
Closed -$221K

Similar funds

O'Brien Greene & Co's Q1 2026 Portfolio in Review

As of Q1 2026, O'Brien Greene & Co held 147 positions worth $353M, up 4.9% from $337M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

O'Brien Greene & Co's Q1 2026 filing shows 11 new, 37 increased, 34 reduced and 14 closed positions. Its largest new stake was ABB Ltd: 83,442 shares worth $6.72M. The largest sale was Medpace, an estimated $7.16M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Energy and Technology.

  • O'Brien Greene & Co's largest Q1 2026 buy was ABB Ltd: 83,442 shares worth $6.72M.
  • O'Brien Greene & Co added most to Ecopetrol in Q1 2026, an estimated $684K increase.
  • O'Brien Greene & Co's biggest Q1 2026 reduction was FedEx, cutting an estimated $4.27M.
  • O'Brien Greene & Co fully exited Medpace in Q1 2026, selling an estimated $7.16M.
  • O'Brien Greene & Co's ten largest holdings make up 40% of its $353M portfolio in Q1 2026.
  • O'Brien Greene & Co opened 11 new positions and closed 14 in Q1 2026.
  • O'Brien Greene & Co's portfolio value rose 4.9% quarter-over-quarter to $353M.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.